Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Carlos David Azuara-Galindo"'
Autor:
Jose Navarro-Partida, Juan Carlos Altamirano-Vallejo, Luis Abraham Aceves Franco, Jesús Gonzalez-Cortes, Sergio Hernandez-Da Mota, Jose Gerardo García-Aguirre, Carlos David Azuara-Galindo, Carlos Rodrigo Castro-Castaneda, Juan Armendariz-Borunda, Arturo Santos
Publikováno v:
Pharmaceutics, Vol 13, Iss 9, p 1491 (2021)
Novel strategies have been developed to reduce or avoid intravitreal injections (IVTs) of the antiangiogenic (ranibizumab (RBZ)) and anti-inflammatory (triamcinolone acetonide (TA)) agents used to treat vitreoretinal diseases. One of the strategies i
Externí odkaz:
https://doaj.org/article/a96b50111720467b8347cf20fc6be8c3
Autor:
Sergio E. Hernandez-Da Mota, Jose Gerardo García-Aguirre, Carlos Rodrigo Castro-Castaneda, Arturo Santos, Jose Navarro-Partida, Jesús Hernán González-Cortés, Luis Abraham Aceves Franco, Juan Armendáriz-Borunda, Carlos David Azuara-Galindo, Juan C. Altamirano-Vallejo
Publikováno v:
Pharmaceutics
Volume 13
Issue 9
Pharmaceutics, Vol 13, Iss 1491, p 1491 (2021)
Volume 13
Issue 9
Pharmaceutics, Vol 13, Iss 1491, p 1491 (2021)
Novel strategies have been developed to reduce or avoid intravitreal injections (IVTs) of the antiangiogenic (ranibizumab (RBZ)) and anti-inflammatory (triamcinolone acetonide (TA)) agents used to treat vitreoretinal diseases. One of the strategies i
Autor:
Juan C. Altamirano-Vallejo, Juan Armendáriz-Borunda, Jesús Hernán González-Cortés, Sergio Hernandez Da Mota, Arturo Santos, Luis Abraham Aceves Franco, Jose Navarro-Partida, Carlos Rodrigo Castro-Castaneda, Jose Gerardo García-Aguirre, Carlos David Azuara-Galindo
Novel strategies have been developed to reduce or to avoid the intravitreal injections (IVTs) of the antiangiogenic (ranibizumab; RBZ) and the anti-inflammatory (triamcinolone acetonide; TA) agents used to treat vitreoretinal diseases. One of the str
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29d2cfa4108a7f20210cc77c38aa8024